Niels Emil Ulrich Hermansen (Emil Hermansen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

European journal of haematology

American journal of hematology

Blood cancer journal

PloS one

Zealand University Hospital

University of Copenhagen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zealand University Hospital Nov 01 2017

Denmark

Staff specialist :: Hematology

Education History

University of Copenhagen Jan 01 2008 - Sep 19 2016

Denmark

PHD :: Clinical Medicine

Publications

Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, Mette Bøegh Levring, Carsten Helleberg, Niels Emil Ulrich Hermansen, Søren Thorgaard Bønløkke, Katrine Nielsen, Elena Manuela Teodorescu, Eva Kurt, Casper Nørgaard Strandholdt, Annette Juul Vangsted
The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies. EJHaem 4 (4) (2023)
Lise Dueholm Bertelsen, Lars Børty, Heidi Søgaard Christensen, Martin Bøgsted, Henrik Gregersen, Robert Schou Pedersen, Anja Klostergaard, Brian Iversen Schnack, Per Trøllund Pedersen, Niels Abildgaard, Niels Emil Ulrich Hermansen, Annette Juul Vangsted, Marianne Tang Severinsen
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation. European journal of haematology (2022)
Karen Louise Højholt, Henrik Gregersen, Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Niels Emil Ulrich Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Katrine Fladeland Iversen, Elena Manuela Teodorescu, Eva Kurt, Casper Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients. Hematological oncology 39 (4) (2021)
Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Niels Emil Ulrich Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Elena Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Nørgaard Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy. American journal of hematology 97 (3) (2021)
Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Niels Emil Ulrich Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Katrine Fladeland Iversen, Elena Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted
The real-world outcomes of multiple myeloma patients treated with daratumumab. PloS one 16 (10) (2021)
Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Niels Abildgaard, Henrik Gregersen, Trine Silkjær, Per Trøllund Pedersen, Robert Schou Pedersen, Carsten Helleberg, Niels Emil Ulrich Hermansen, Brian Iversen Schnack, Annette Juul Vangsted
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio. Blood cancer journal 11 (4) (2021)
Cecilie Hveding Blimark, Annette Juul Vangsted, Tobias W Klausen, Henrik Gregersen, Agoston Gyula Szabo, Niels Emil Ulrich Hermansen, Göran Wålinder, Dorota Knut-Bojanowska, Chenyang Zang, Ingemar Turesson, null null
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries. European journal of haematology (2021)
Konstantinos Dimopoulos, Alexandra Søgaard Helbo, Helga Fibiger Munch-Petersen, Lene Sjö, Jesper Christensen, Lasse Sommer Kristensen, Fazila Asmar, Niels Emil Ulrich Hermansen, Casey O'Connel, Peter Gimsing, Gangning Liang, Kirsten Grønbaek
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner. Molecular oncology 12 (2) (2017)

Niels Emil Ulrich Hermansen.css-eqlu8i{font-size:small;padding-left:4px;} (Emil Hermansen)

Publication Activity (10 Years)

Top Topics

Top Venues

Niels Emil Ulrich Hermansen (Emil Hermansen)